Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda
NCT03508349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1786
Last updated 2019-12-06
Summary
The main aim of this study is to test the primary hypothesis that the addition of intermittent screening and treatment of malaria in pregnant women (ISTp) who receive routine antenatal care (ANC) in health facilities in high malaria transmission areas in Rwanda will reduce malaria prevalence among pregnant women when compared to routine antenatal cares services alone.
Conditions
- Malaria in Pregnancy
Interventions
- DIAGNOSTIC_TEST
-
IST
Women in the control group will receive routine care, which does not include testing for malaria with a rapid diagnostic test unless symptomatic for malaria. Women in the intervention group will receive this additional testing for malaria at each antenatal care, regardless of whether she is symptomatic for malaria.
Sponsors & Collaborators
-
Rwanda Malaria and Other Parasitic Diseases Division (MOPDD)
collaborator UNKNOWN -
Centers for Disease Control and Prevention
collaborator FED -
Jhpiego
lead OTHER
Principal Investigators
-
Reena Sethi, DrPH · Jhpiego
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-05
- Primary Completion
- 2018-10-31
- Completion
- 2019-03-18
Countries
- Rwanda
Study Locations
More Related Trials
-
Chlorproguanil-Dapsone in Pregnant Women
NCT00126971 ·Status: TERMINATED ·Phase: PHASE1
-
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
NCT04336189 ·Status: COMPLETED ·Phase: PHASE3
-
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
NCT00140517 ·Status: COMPLETED ·Phase: NA
-
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
NCT04158713 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
NCT00132535 ·Status: COMPLETED ·Phase: NA
-
Monitoring Pregnant Women for Antimalarial Drug Resistance
NCT05072613 ·Status: COMPLETED
-
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
NCT05757167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in Pregnancy
NCT01053325 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
NCT00811421 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of the Histidine Rich Protein 2 (HRP2) Highly Sensitive Rapid Diagnostic Test (HS-RDT) for Malaria Diagnosis in Pregnant Women in Papua New Guinea
NCT03462615 ·Status: UNKNOWN
-
Efficacy of Combination Therapy for Prevention of Effects of Malaria During Pregnancy
NCT00164255 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of ISTp- PYRAMAX-US-RDT to IPTp-SP to Prevent Malaria in Pregnant Women in DRC (ULTRAPYRAPREG)
NCT04783051 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
NCT00970879 ·Status: COMPLETED ·Phase: PHASE3
-
Intermittent Preventive Treatment With Dihydroartemisinin-piperaquine in Papua, Indonesia
NCT05294406 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Safety of Dihydroartemisinin-Piperaquine Amongst Pregnant Women in Tanzania
NCT02909712 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Antifolates Against Malaria in HIV-infected Pregnant Women and the Emergence of Induced Resistance in Plasmodium Falciparum
NCT01746199 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetics, Efficacy, Gametocyte Carriage, Birth Outcomes Following Sulfadoxine-pyrimethamine Intermittent Presumptive Treatment in Pregnant Women
NCT00380146 ·Status: COMPLETED ·Phase: NA
-
Sulfadoxine-pyrimethamine Plus Dihydroartemisinin-piperaquine for Intermittent Preventive Treatment in Pregnancy
NCT05426434 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Pregnant Women for Malaria Surveillance
NCT04412005 ·Status: COMPLETED
-
Daily Co-trimoxazole Prophylaxis to Prevent Malaria in Pregnancy
NCT00711906 ·Status: TERMINATED ·Phase: PHASE3
-
Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy
NCT01916954 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of Congo
NCT00538382 ·Status: COMPLETED ·Phase: PHASE1
-
Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy
NCT07021430 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa
NCT01103063 ·Status: TERMINATED ·Phase: PHASE3
-
Acceptability and Feasibility in the Context of the IMPROVE Trial in Kenya
NCT04160026 ·Status: COMPLETED ·Phase: PHASE4